Dr. Reddy's Laboratories has launched Ziprasidone Hydrochloride Capsules, a bioequivalent generic version of Geodon in the US market on March 2, 2012 following the approval by the United States Food & Drug Administration (USFDA) of Dr. Reddy's ANDA for Ziprasidone Hydrochloride Capsules.
The Geodon brand had US sales of approximately $1.34 billion for the most recent twelve months ending December 2011 according to IMS Health.
Dr. Reddy's Ziprasidone Hydrochloride Capsules in 20mg, 40mg, 60mg and 80mg strengths are available in 60 count bottle size.
Dr Reddy's is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products - the company offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, biosimilars, differentiated formulations and NCEs.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1815.00 |
Dr. Reddys Lab | 1351.50 |
Cipla | 1476.15 |
Lupin | 2172.00 |
Zydus Lifesciences | 974.65 |
View more.. |